XML 51 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Goodwill and Other Intangible Assets (Tables)
9 Months Ended
Oct. 01, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
 
 
December 31, 2015
 
Business acquisitions
 
Purchase accounting adjustments
 
Impairments
 
Changes in assets held for sale
 
Currency translation adjustment
 
October 1,
2016
Reportable Segments:
 
Restated
 
Restated
 
Restated
 
Restated
 
Restated
 
Restated
 
Restated
CHC
 
$
1,890.0

 
$

 
$

 
$

 
$
4.5

 
$
(6.6
)
 
$
1,887.9

BCH
 
1,769.4

 

 
0.7

 
(868.5
)
 

 
67.9

 
969.5

Rx
 
1,222.2

 
1.8

 

 

 

 
(13.8
)
 
1,210.2

Specialty Sciences
 
199.6

 

 

 

 

 

 
199.6

Other
 
71.5

 

 

 

 
11.7

 
3.1

 
86.3

Total goodwill
 
$
5,152.7

 
$
1.8

 
$
0.7

 
$
(868.5
)
 
$
16.2

 
$
50.6

 
$
4,353.5

Schedule of finite and indefinite-lived intangible assets
Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
October 1, 2016
 
December 31, 2015
 
Restated
 
Restated
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
$
311.3

 
$
106.2

 
$
242.4

 
$
77.7

Developed product technology, formulations, and product rights
1,804.4

 
529.0

 
1,387.6

 
426.0

Customer relationships and distribution networks
1,564.0

 
288.8

 
1,520.7

 
193.0

Trademarks, trade names, and brands
631.6

 
54.7

 
539.4

 
22.8

Non-compete agreements
14.6

 
11.0

 
15.2

 
12.7

Total definite-lived intangibles
$
4,325.9

 
$
989.7

 
$
3,705.3

 
$
732.2

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
724.2

 
$

 
$
1,868.1

 
$

In-process research and development
67.9

 

 
48.2

 

Total indefinite-lived intangibles
792.1

 

 
1,916.3

 

Total other intangible assets
$
5,118.0

 
$
989.7

 
$
5,621.6

 
$
732.2